Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$8.15 - $13.9 $139,153 - $237,328
-17,074 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$12.3 - $18.2 $32,939 - $48,739
-2,678 Reduced 13.56%
17,074 $210,000
Q4 2020

Feb 02, 2021

SELL
$14.94 - $18.3 $5,976 - $7,320
-400 Reduced 1.98%
19,752 $361,000
Q3 2020

Nov 05, 2020

BUY
$15.45 - $18.12 $311,348 - $365,154
20,152 New
20,152 $315,000

Others Institutions Holding FRLN

# of Institutions
1
Shares Held
30.1K
Call Options Held
0
Put Options Held
0

About Freeline Therapeutics Holdings plc


  • Ticker FRLN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,972,300
  • Description
  • Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its advanced product candidate is verbrinacogene setparvovec (FLT180a), a gene therapy product candidate that is in P...
More about FRLN
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.